stars 1 stars 2 stars 3

CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, CStone has received ten NDA approvals for four drugs. Multiple late-stage drug candidates are now under pivotal clinical trials or registration. CStone's vision is to become globally recognized as a world-renowned biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.

View Top Employees from CStone Pharmaceuticals

CStone Pharmaceuticals Questions

The CStone Pharmaceuticals annual revenue was $14 million in 2024.

Frank 江宁军 is the Chairman and Chief Executive Officer of CStone Pharmaceuticals.

191 people are employed at CStone Pharmaceuticals.

CStone Pharmaceuticals is based in Shanghai, Shanghai.

The NAICS codes for CStone Pharmaceuticals are [3254, 32541, 325, 32].

The SIC codes for CStone Pharmaceuticals are [28, 283].

Top CStone Pharmaceuticals Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users